The Digital Pathology Association (DPA) recently announced its suggestion that digital pathology manufacturers currently interested in marketing Whole Slide Imaging (WSI) devices for primary diagnosis in the United States submit de novo applications to the Food and Drug Administration (FDA) based on clarity and guidance provided to the DPA from the FDA.
Unless otherwise stated, all texts, graphics, user interface, visual interface, images, and computer codes (referred to collectively as the Contents) on the Website, including but not limited to the design, structure, selection, coordination, expression, look of interface or images and sorting of these Contents, are all owned by the Digital Pathology Association or its licensor. We are not responsible for the display of the cell images, as they are rendered on different browsers and platforms. Images on this site should not be used in the assessment or diagnosing process. Please contact the DPA, for more information.